RAC 3.79% $1.53 race oncology ltd

Speculative M&A Transaction Analysis, page-637

  1. 387 Posts.
    lightbulb Created with Sketch. 70
    Because Race (Zantrene) would have already been purchased by Merck, J&J or Otsuka...
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.